We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$150B
Turnover
14.09%
1-Year Est. Return
40.08%
This Fund
S&P 500
This Quarter
Est. Return
+12.24%
1 Year Est. Return
+40.08%
3 Year Est. Return
+113.08%
5 Year Est. Return
+141.06%
10 Year Est. Return
+565.4%
AUM
$130B
AUM Growth
+$10.6B
(+8.8%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
21.27%
Holding
2,138
New
167
Increased
1,007
Reduced
798
Closed
89
Avg Time Held Equity + Options
5.5
years
Top 10 Avg Time Held Equity + Options
5.6
years
Top 20 Avg Time Held Equity + Options
4.4
years
Avg Time Held Equity only
5.5
years
Top 10 Avg Time Held Equity only
5.6
years
Top 20 Avg Time Held Equity only
4.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$338M |
| 2 |
Meta Platforms (Facebook)
META
|
+$297M |
| 3 |
Boeing
BA
|
+$208M |
| 4 |
UnitedHealth
UNH
|
+$183M |
| 5 |
Linde
LIN
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kroger
KR
|
+$306M |
| 2 |
Accenture
ACN
|
+$268M |
| 3 |
Goldman Sachs
GS
|
+$191M |
| 4 |
Palantir
PLTR
|
+$169M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.98% |
| 2 | Financials | 14.56% |
| 3 | Industrials | 11.84% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Healthcare | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
H&R Block
HRB
$5.92B
| $1.58M | ﹤0.01% |
28,871
+19,067
| +194% | +$1.1M |
2022 Q2
12 quarters
|
|
1202
East-West Bancorp
EWBC
$17.3B
| $1.58M | ﹤0.01% |
15,647
-1,311
| -8% | -$116K |
2021 Q4
14 quarters
|
|
1203
Xcel Energy
XEL
$46.9B
| $1.57M | ﹤0.01% |
23,081
+1,775
| +8% | +$123K |
2015 Q2
40 quarters
|
|
1204
Healthpeak Properties
DOC
$13.1B
| $1.57M | ﹤0.01% |
89,501
-33,318
| -27% | -$592K |
2013 Q2
48 quarters
|
|
1205
Petrobras
PBR
$163B
| $1.56M | ﹤0.01% |
124,471
+9,435
| +8% | +$113K |
2021 Q4
14 quarters
|
|
1206
DELISTED
Hologic
HOLX
| $1.55M | ﹤0.01% |
23,800
+8,469
| +55% | +$508K |
2019 Q2
24 quarters
|
|
1207
Sanofi
SNY
$96.5B
| $1.54M | ﹤0.01% |
31,878
-5,338
| -14% | -$273K |
2013 Q2
48 quarters
|
|
1208
Expeditors International
EXPD
$25.8B
| $1.53M | ﹤0.01% |
13,414
-10
| -0.1% | -$1.12K |
2020 Q2
20 quarters
|
|
1209
Triumph Financial Inc
TFIN
$1.48B
| $1.53M | ﹤0.01% |
27,790
-1,262
| -4% | -$70.3K |
2024 Q2
4 quarters
|
|
1210
Performance Food Group
PFGC
$15.3B
| $1.52M | ﹤0.01% |
17,332
+298
| +2% | +$24.8K |
2020 Q2
20 quarters
|
|
1211
VNET Group
VNET
$1.26B
| $1.52M | ﹤0.01% |
219,633
+74,802
| +52% | +$448K |
2025 Q1
1 quarter
|
|
1212
Evercore
EVR
$9.87B
| $1.51M | ﹤0.01% |
5,583
-1,992
| -26% | -$438K |
2023 Q4
6 quarters
|
|
1213
CAE Inc
CAE
$7.7B
| $1.51M | ﹤0.01% |
51,521
+40,842
| +382% | +$1.03M |
2025 Q1
1 quarter
|
|
1214
Avantor
AVTR
$10.9B
| $1.5M | ﹤0.01% |
111,606
-1,146
| -1% | -$15.7K |
2019 Q2
24 quarters
|
|
1215
Endava
DAVA
$109M
| $1.5M | ﹤0.01% |
98,054
+13,781
| +16% | +$232K |
2023 Q4
6 quarters
|
|
1216
PPL Corp
PPL
$25.9B
| $1.5M | ﹤0.01% |
44,271
+6,668
| +18% | +$232K |
2013 Q2
48 quarters
|
|
1217
Stifel
SF
$10.4B
| $1.49M | ﹤0.01% |
21,516
+2,887
| +15% | +$177K |
2023 Q1
9 quarters
|
|
1218
The Kraft Heinz Company
KHC
$27.6B
| $1.48M | ﹤0.01% |
57,346
-13,628
| -19% | -$378K |
2015 Q3
39 quarters
|
|
1219
Halliburton
HAL
$27.4B
| $1.48M | ﹤0.01% |
72,450
+34,860
| +93% | +$731K |
2013 Q2
48 quarters
|
|
1220
Conagra Brands
CAG
$6.77B
| $1.47M | ﹤0.01% |
71,953
-12,651
| -15% | -$296K |
2013 Q2
48 quarters
|
|
1221
AXIS Capital
AXS
$7.15B
| $1.47M | ﹤0.01% |
14,119
+2,907
| +26% | +$289K |
2021 Q4
14 quarters
|
|
1222
Veeva Systems
VEEV
$50.7B
| $1.46M | ﹤0.01% |
5,087
+561
| +12% | +$139K |
2017 Q3
31 quarters
|
|
1223
Qiagen
QGEN
$9.53B
| $1.46M | ﹤0.01% |
30,478
+11,126
| +57% | +$484K |
2024 Q3
3 quarters
|
|
1224
Elanco Animal Health
ELAN
$11.8B
| $1.45M | ﹤0.01% |
101,775
-1,085,726
| -91% | -$12.7M |
2023 Q2
8 quarters
|
|
1225
Oklo
OKLO
$5.58B
| $1.45M | ﹤0.01% |
25,907
-82
| -0.3% | -$3.16K |
2024 Q4
2 quarters
|
|
Similar funds
Neuberger Berman Group's Q2 2025 Portfolio in Review
As of Q2 2025, Neuberger Berman Group held 2,138 positions worth $130B, up 8.8% from $119B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Neuberger Berman Group's Q2 2025 filing shows 167 new, 1,007 increased, 798 reduced and 89 closed positions. Its largest new stake was Caris Life Sciences: 6,239,520 shares worth $167M. The largest sale was Kroger, an estimated $306M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Neuberger Berman Group's largest Q2 2025 buy was Caris Life Sciences: 6,239,520 shares worth $167M.
- Neuberger Berman Group added most to Home Depot in Q2 2025, an estimated $338M increase.
- Neuberger Berman Group's biggest Q2 2025 reduction was Kroger, cutting an estimated $306M.
- Neuberger Berman Group fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2025, selling an estimated $73.6M.
- Neuberger Berman Group's ten largest holdings make up 21% of its $130B portfolio in Q2 2025.
- Neuberger Berman Group opened 167 new positions and closed 89 in Q2 2025.
- Neuberger Berman Group's portfolio value rose 8.8% quarter-over-quarter to $130B.
Based on Neuberger Berman Group's 13F filing for Q2 2025, filed 13 Aug 2025.